Old Web
English
Sign In
Acemap
>
authorDetail
>
Shouryadeep Srivastava
Shouryadeep Srivastava
Millennium Pharmaceuticals
Immunology
Medicine
Myeloid leukemia
Ponatinib
Internal medicine
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Major Adverse Cardiac, Arterial Occlusive, and Venous Occlusive Events Among Chronic Myeloid Leukemia Patients Prescribed Ponatinib Vs Bosutinib
2019
Blood
Moshe Yair Levy
Lin Xie
Yuexi Wang
Frank Neumann
Shouryadeep Srivastava
Daniel Naranjo
Jing Xu
Qisu Zhang
Mehul Dalal
Show All
Source
Cite
Save
Citations (0)
Development and Validation of a Highly Sensitive e1a2 (p190) BCR-ABL Test to Determine Complete Molecular Response (Minimal Residual Disease Negative) As a Primary Endpoint for Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
2018
Blood
Kristy Drafahl
David C. Smith
Cristen Graham
Christine Glynn
Cindy Spittle
Scott Verrow
Victor M. Rivera
Shouryadeep Srivastava
Kevin Hawkins
Chad Galderisi
Show All
Source
Cite
Save
Citations (0)
Real-World Comparisons of Cardiovascular Events between Different Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia
2018
Blood
Moshe Yair Levy
Lin Xie
Yuexi Wang
Frank Neumann
Shouryadeep Srivastava
Daniel Naranjo
Qisu Zhang
Mehul Dalal
Show All
Source
Cite
Save
Citations (0)
1